CXCR1/IL-8RA Antibody (1122A) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # FAB8628M
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 1122A
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse CXCR1/IL‑8 RA Peptide
Accession # Q810W6
Accession # Q810W6
Specificity
Detects mouse CXCR1 transfectants but not CXCR2 transfectants by flow cytometry.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for CXCR1/IL-8RA Antibody (1122A) [DyLight 594]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CXCR1/IL-8RA
Long Name
Interleukin 8 Receptor A
Alternate Names
CD181, IL-8 RA, IL8RA
Gene Symbol
CXCR1
Additional CXCR1/IL-8RA Products
Product Documents for CXCR1/IL-8RA Antibody (1122A) [DyLight 594]
Product Specific Notices for CXCR1/IL-8RA Antibody (1122A) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...